About Orpyx
Orpyx is a company based in Calgary (Canada) founded in 2010 by Marcel Groenland and Breanne Everett. Orpyx has raised $25.61 million across 3 funding rounds from investors including Perceptive Advisors, Aphelion Capital and Thin Air Labs. Orpyx offers products and services including Sensory Insole System, Provider Dashboard, and Remote Patient Monitoring. Orpyx operates in a competitive market with competitors including Dexcom, mySugr, Levels, Biolinq and Indigo, among others.
- Headquarter Calgary, Canada
- Founders Marcel Groenland, Breanne Everett
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Orpyx Medical Technologies Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$25.61 M (USD)
in 3 rounds
-
Latest Funding Round
$20 M (USD), Series B
Sep 24, 2024
-
Investors
Perceptive Advisors
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Orpyx
Orpyx offers a comprehensive portfolio of products and services, including Sensory Insole System, Provider Dashboard, and Remote Patient Monitoring.
Wearable insole that monitors pressure and temperature to prevent foot ulcers.
Tool for tracking patient data and insights in diabetes management.
Program offering virtual coaching and data analysis for diabetes care.
People of Orpyx
Unlock access to complete
Unlock access to complete
Funding Insights of Orpyx
Orpyx has successfully raised a total of $25.61M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $20 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Orpyx
Orpyx has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Perceptive Advisors, Aphelion Capital and Thin Air Labs.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Locked | Locked | Locked | |
|
Tech and life sciences focused VC firm investing in geographies such as the US
|
Locked | Locked | Locked | |
|
Thin Air Labs is engaged in venture capital and startup support services.
|
Locked | Locked | Locked |
Investor details for Orpyx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Orpyx
Investment portfolio details for Orpyx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Orpyx
Detailed financials for Orpyx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Orpyx Comparisons
Peer comparison for Orpyx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Orpyx
Orpyx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, mySugr, Levels, Biolinq and Indigo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable glucose monitoring patches are provided for real-time data tracking.
|
|
| Locked | Locked | Locked |
Gamified apps for diabetes management and therapy are provided.
|
|
| Locked | Locked | Locked |
Wearable devices for metabolic health insights are provided.
|
|
| Locked | Locked | Locked |
Wearable biosensor platform for real-time diabetes monitoring is provided.
|
|
| Locked | Locked | Locked |
Parking management and mobility solutions are provided by Indigo.
|
|
| Locked | Locked | Locked |
Continuous glucose monitoring system is provided for blood sugar levels.
|
Detailed competitors of Orpyx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Orpyx
Complete news archive for Orpyx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Orpyx
Orpyx was founded in 2010 and raised its 1st funding round 10 years after it was founded.
Orpyx is headquartered in Calgary, Canada. It is registered at Calgary, Alberta, Canada.
Breanne Everett is the current CEO of Orpyx. They have also founded this company.
Orpyx is a funded company, having raised a total of $25.61M across 3 funding rounds to date.
Wearable devices for neuropathy patients and athletes. It develops a sensor-based product, Orpyx SI, the sensory insoles with remote patient monitoring allows users to manage and prevent diabetic foot ulcers and limb loss through advanced foot sensor technology and real-time analytics. The insoles can fit above the shoe and capture pressure data from the users feet. The pressure data is then wirelessly transmitted from the shoe inserts to a smartwatch. The smartwatch alerts the user at extreme pressure levels to modify their behaviour and avoid damage. The device can be used to track neuropathy and is FDA cleared. Other product lines include SurroSense Rx system, Orpyx LogR solution and SurroGai Rx system.
Orpyx offers Sensory Insole System, Provider Dashboard, and Remote Patient Monitoring.
Orpyx has 8 investors. Key investors include Perceptive Advisors, Aphelion Capital, Thin Air Labs, InterGen, and Relentless Venture Fund.